Immunohistochemical analysis revealed CD34 and Ki67 protein expression as significant prognostic factors in colorectal cancer

Medical Oncology

Volumn 27, Issue 2, 2010, Pages 304-309

  Ma, Yan Lei ^a   Peng, Jia Yuan ^a   Zhang, Peng ^a   Liu, Wei Jie ^a   Huang, Long ^a   Qin, Huan Long ^a  

^a SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

Author keywords

Angiogenesis; CD34; Colorectal cancer; Ki67; Prognosis

Indexed keywords

CD34 ANTIGEN; KI 67 ANTIGEN;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; COLORECTAL CANCER; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

AGED; ANTIGENS, CD34; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 77956927753     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12032-009-9210-3     Document Type: Article

References (28)

1. Weitz J, Koch M, Debus J, et al. Colorectal cancer. Lancet. 2005;16:280-8.
2. You WC, Jin F, Devesa S, et al. Rapid increase in colorectal cancer rates in urban Shanghai, 1972-97, in relation to dietary changes. J Cancer Epidemiol Prev. 2002;7:143-6.
3. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin. 2005;55:10-30. doi:10.3322/canjclin.55.1.10.
4. Woolf SH. The best screening test for colorectal cancer-a personal choice. N Engl J Med. 2000;343:1641-3. doi:10.1056/NEJM2000 11303432211.
5. Walsh JM, Terdiman JP. Colorectal cancer screening: scientific review. JAMA. 2003;289:1288-96. doi:10.1001/jama.289.10.1288. (Pubitemid 37432910)
6. Celis JE, Gromov P. Proteomics in translation cancer research: toward an integrated approach. Cancer Cell. 2003;3:9-15. doi: 10.1016/S1535-6108(02)00242- 8. (Pubitemid 37448548)
7. Ahlquist DA. Fecal occult blood testing for colorectal cancer. Can we afford to do this? Gastroenterol. Clin North Am. 1997;26:41-55. doi:10.1016/S0889-8553(05)70282-X. (Pubitemid 27104403)
8. Collins JF, Lieberman DA, Durbin TE, et al. Accuracy of screening for fecal occult blood on a single stool sample obtained by digital rectal examination: a comparison with recommended sampling practice. Ann Intern Med. 2005;142:81-5.
9. Geenen JE, Schmitt MG Jr, Wu WC, et al. Major complications of coloscopy: bleeding and perforation. Am J Dig Dis. 1975;20:231-5. doi:10.1007/BF01070726.
10. Silvis SE, Nebel O, Rogers G, et al. Endoscopic complications: results of the 1974 American Society for gastrointestinal endoscopy survey. J Am Med Assoc. 1976;235:928-30. doi:10.1001/ jama.235.9.928.
11. Winawer S, Fletcher R, Rex D, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale-update based on new evidence. Gastroenterology. 2003;124:544-60. doi:10.1053/ gast.2003.50044.
12. Roessler M, Rollinger W, Mantovani-Endl L, et al. Identification of PSME3 as a novel serum tumor marker for colorectal cancer by combining two-dimensional polyacrylamide gel electrophoresis with a strictly mass spectrometry-based approach for data analysis. Mol Cell Proteomics. 2006;5:2092-101. doi:10.1074/mcp. M600118-MCP200.
13. American Society of Clinical Oncology: clinical practice guidelines for the use of tumor markers in breast and colorectal cancer. Adopted on May 17, 1996 by the American Society of Clinical Oncology. J Clin Oncol. 1996;14:2843-77.
14. Bast RC Jr, Ravdin P, Hayes DF, et al. 2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol. 2001;19:1865-78.
15. da Silva BB, Pires CG, Dos Santos AR, et al. Effects of raloxifene on Ki-67 and CD34 antigen expression in breast cancer. Gynecol Obstet Invest. 2008;67:103-8. doi:10.1159/000165512.
16. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst. 1990;82:4-6. doi:10.1093/jnci/82.1.4.
17. Weidner N, Semple JP, Welche WR, et al. Tumor angiogenesis and metastasis correlation in invasive breast carcinoma. N Engl J Med. 1991;324:1-8.
18. Folkman J. Angiogenesis and breast cancer. J Clin Oncol. 1994;12:441-3.
19. Nieto Y, Woods J, Nawaz F, et al. Prognostic analysis of tumour angiogenesis, determined by microvessel density and expression of vascular endothelial growth factor, in high-risk primary breast cancer patients treated with high-dose chemotherapy. Br J Cancer. 2007;97:391-7. doi:10.1038/sj.bjc. 6603875. (Pubitemid 47196747)
20. Vieira SC, Silva BB, Pinto GA, et al. CD34 as a marker for evaluating angiogenesis in cervical cancer. Pathol Res Pract. 2005;201:313-8. doi:10.1016/j.prp.2005.01.010. (Pubitemid 40668482)
21. Miettinen M, Sobin LH, Lasota J. Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long term follow-up. Am J Surg Pathol. 2005;29:522-68.
22. Li Z, Zhao X, Bai S, et al. Proteomics identification of cyclophilin a as a potential prognostic factor and therapeutic target in endometrial carcinoma. Mol Cell Proteomics. 2008;7:1810-23. doi:10.1074/mcp.M700544-MCP200.
23. Kreisberg JI, Malik SN, Prihoda TJ, et al. Phosphorylation of Akt (Ser473) is an excellent predictor of poor clinical outcome in prostate cancer. Cancer Res. 2004;64:5232-6. doi:10.1158/0008- 5472.CAN-04-0272.
24. Feng YZ, Shiozawa T, Miyamoto T, et al. Overexpression of hedgehog signaling molecules and its involvement in the proliferation of endometrial carcinoma cells. Clin Cancer Res. 2007;13:1389-98. doi:10.1158/1078-0432.CCR-06- 1407. (Pubitemid 46450427)
25. Fox SB, Gatter KC, Bicknell R, et al. Relationship of endothelial cell proliferation to tumor vascularity in human breast cancer. Cancer Res. 1993;53:4161-3.
26. Vartanian RK, Weidner N. Correlation of intratumoral endothelial cell proliferation with microvessel density (tumor angiogenesis) and tumor cell proliferation in breast carcinoma. Am J Pathol. 1994;144:1188-94.
27. Rudolph P, Peters J, Lorenz D, et al. Correlation between mitotic and Ki-67 labeling indices in paraffin-embedded carcinoma specimens. Hum Pathol. 1998;29:1216-22. doi:10.1016/S0046- 8177(98)90248-9.
28. Leek RD. The prognostic role of angiogenesis in breast cancer. Anticancer Res. 2001;21:4325-31.